Urology & Nephrology Open Access Journal
Abstract
It is challenging to identify the aetiology of acute kidney injury in cancer patients since it can be multifactorial.Renal-limited thrombotic microangiopathy (rTMA) is a rare but recognized complication associated with certain antineoplastic therapies.Diagnosing rTMA in the context of bevacizumab therapy requires a high level of suspicion.In here, we report steroid responsive acute kidney injury associated with induction therapy with bevacizumab therapy.
Publication details
- Journal / source
- Urology & Nephrology Open Access Journal
- Publisher
- MedCrave Group Kft.
- Publication date
- 3 April 2026
- Language
- EN